Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1956 1
1957 1
1958 2
1959 2
1960 2
1961 1
1962 8
1963 14
1964 5
1965 6
1966 7
1967 8
1968 13
1969 10
1970 13
1971 10
1972 17
1973 11
1974 20
1975 15
1976 13
1977 12
1978 11
1979 19
1980 22
1981 17
1982 34
1983 30
1984 27
1985 45
1986 40
1987 48
1988 78
1989 57
1990 70
1991 80
1992 88
1993 105
1994 130
1995 158
1996 166
1997 167
1998 192
1999 206
2000 283
2001 336
2002 376
2003 404
2004 519
2005 679
2006 799
2007 912
2008 1074
2009 1230
2010 1411
2011 1676
2012 1844
2013 2085
2014 2273
2015 2463
2016 2535
2017 2835
2018 3051
2019 3536
2020 4223
2021 5011
2022 5501
2023 5523
2024 2394

Text availability

Article attribute

Article type

Publication date

Search Results

49,048 results

Results by year

Filters applied: . Clear all
Page 1
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.
Jin YN, Qiang MY, Wang Y, Lin YJ, Jiang RW, Cao WW, Zhang WJ, Wang SY, Zhang HY, Yao JJ. Jin YN, et al. Among authors: lin yj. Cancer Immunol Immunother. 2024 May 11;73(7):125. doi: 10.1007/s00262-024-03698-2. Cancer Immunol Immunother. 2024. PMID: 38733402
49,048 results
You have reached the last available page of results. Please see the User Guide for more information.